BCP
SNOA icon

Blackhawk Capital Partners’s Sonoma Pharmaceuticals SNOA Stock Holding History

Blackhawk Capital Partners’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3
Closed -$2K – 245
2018
Q2 		$2K Hold
3
– – ﹤0.01% 304
2018
Q1 		$2K Hold
3
– – ﹤0.01% 312
2017
Q4 		$3K Buy
+3
New +$2.57K ﹤0.01% 271

Other funds holding SNOA

BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Blackhawk Capital Partners's SNOA Position: Q3 2018 in Review

Blackhawk Capital Partners sold out of Sonoma Pharmaceuticals (SNOA) in Q3 2018, closing a stake of 3 shares — an estimated $2K sold.

Blackhawk Capital Partners first reported a position in SNOA in Q4 2017 and held it in 3 quarters. The position peaked at $3K in Q4 2017. 23 funds tracked by Wall St. Rank hold SNOA as of Q3 2018.

  • Blackhawk Capital Partners reported no remaining Sonoma Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Blackhawk Capital Partners sold 3 Sonoma Pharmaceuticals shares in Q3 2018, an estimated $2K.
  • Blackhawk Capital Partners first reported a position in Sonoma Pharmaceuticals in Q4 2017 and held it in 3 quarters.
  • Blackhawk Capital Partners's Sonoma Pharmaceuticals position peaked at $3K in Q4 2017.
  • 23 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2018.

Based on Blackhawk Capital Partners's 13F filing for Q3 2018, filed 13 Nov 2018.